Xeris Pharmaceuticals Inc (XERS) — Cash Flow Quality Index
Xeris Pharmaceuticals Inc (XERS) has a Cash Flow Quality Index of 4.42x as of March 2026. Operating cash flow of $9.87 Million exceeds net income of $2.23 Million, indicating high earnings quality where cash backs reported profits. Explore XERS cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Xeris Pharmaceuticals Inc Cash Flow Quality Index (2025–2025)
Historical Cash Flow Quality Index for Xeris Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check XERS capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Xeris Pharmaceuticals Inc (2025–2025)
Year-by-year earnings quality comparison for Xeris Pharmaceuticals Inc. For live market cap and the full company financial profile, see XERS company net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 51.67x | $28.63 Million | $554.00K | — |